FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10842011000001101: Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37251701000001113 Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37251801000001116 Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Is a Deferasirox 250mg dispersible tablets sugar free true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Deferasirox true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Is a Exjade true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Deferasirox true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Is pack of False Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has AMP True Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start